BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22364721)

  • 1. Pulmonary hypertension in canine degenerative mitral valve disease.
    Kellihan HB; Stepien RL
    J Vet Cardiol; 2012 Mar; 14(1):149-64. PubMed ID: 22364721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in dogs: diagnosis and therapy.
    Kellihan HB; Stepien RL
    Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):623-41. PubMed ID: 20610015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005).
    Serres FJ; Chetboul V; Tissier R; Carlos Sampedrano C; Gouni V; Nicolle AP; Pouchelon JL
    J Am Vet Med Assoc; 2006 Dec; 229(11):1772-8. PubMed ID: 17144824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in dogs with mitral regurgitation attributable to myxomatous valve disease.
    Chiavegato D; Borgarelli M; D'Agnolo G; Santilli RA
    Vet Radiol Ultrasound; 2009; 50(3):253-8. PubMed ID: 19507386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systolic arterial blood pressure in small-breed dogs with degenerative mitral valve disease: a prospective study of 103 cases (2007-2012).
    Petit AM; Gouni V; Tissier R; Trehiou-Sechi E; Misbach C; Pouchelon JL; Lefebvre HP; Chetboul V
    Vet J; 2013 Sep; 197(3):830-5. PubMed ID: 23838208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitral valve reconstruction in a toy-breed dog.
    Boggs LS; Dewan SJ; Ballard SE
    J Am Vet Med Assoc; 1996 Dec; 209(11):1872-6. PubMed ID: 8944800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murmur intensity in small-breed dogs with myxomatous mitral valve disease reflects disease severity.
    Ljungvall I; Rishniw M; Porciello F; Ferasin L; Ohad DG
    J Small Anim Pract; 2014 Nov; 55(11):545-50. PubMed ID: 25213440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compounded pimobendan for canine chronic degenerative mitral valve disease and pulmonary hypertension.
    Helms SR; Fox S; Mixon W; Vail J
    Int J Pharm Compd; 2012; 16(1):34-41. PubMed ID: 23050309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs.
    Atkinson KJ; Fine DM; Thombs LA; Gorelick JJ; Durham HE
    J Vet Intern Med; 2009; 23(6):1190-6. PubMed ID: 19780931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of Doppler echocardiography in evaluating pulmonary arterial pressure in patients with mitral valve defect].
    Trojnar R; Rymar B; Wysokiński A; Grzywna R; Wójcik J; Markiewicz M; Rumiński W; Kleinrok A
    Wiad Lek; 1989 May; 42(9):561-6. PubMed ID: 2629323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute mitral regurgitation with papillary muscle rupture in a dog.
    Kaplan PM; Fox PR; Garvey MS; Liu SK; Burk RL
    J Am Vet Med Assoc; 1987 Dec; 191(11):1436-8. PubMed ID: 3692988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Vein-to-Pulmonary Artery Ratio is an Echocardiographic Index of Congestive Heart Failure in Dogs with Degenerative Mitral Valve Disease.
    Merveille AC; Bolen G; Krafft E; Roels E; Gomart S; Etienne AL; Clercx C; Mc Entee K
    J Vet Intern Med; 2015; 29(6):1502-9. PubMed ID: 26415640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine degenerative myxomatous mitral valve disease: natural history, clinical presentation and therapy.
    Borgarelli M; Haggstrom J
    Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):651-63. PubMed ID: 20610017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into degenerative mitral valve disease in dogs.
    Häggström J; Duelund Pedersen H; Kvart C
    Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1209-26, vii-viii. PubMed ID: 15325478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of arteriovenous pulmonary shunts may attenuate the development of pulmonary hypertension in dogs experimentally infected with Angiostrongylus vasorum.
    Matos JM; Schnyder M; Bektas R; Makara M; Kutter A; Jenni S; Deplazes P; Glaus T
    J Vet Cardiol; 2012; 14(2):313-22. PubMed ID: 22575676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987-1991).
    Beardow AW; Buchanan JW
    J Am Vet Med Assoc; 1993 Oct; 203(7):1023-9. PubMed ID: 8135932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired atrial septal defects secondary to rupture of the atrial septum in dogs with degenerative mitral valve disease.
    Peddle GD; Buchanan JW
    J Vet Cardiol; 2010 Aug; 12(2):129-34. PubMed ID: 20584637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on treatment and prognostic indicators in canine myxomatous mitral valve disease.
    Häggström J; Höglund K; Borgarelli M
    J Small Anim Pract; 2009 Sep; 50 Suppl 1():25-33. PubMed ID: 19765217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.
    Keene BW; Atkins CE; Bonagura JD; Fox PR; Häggström J; Fuentes VL; Oyama MA; Rush JE; Stepien R; Uechi M
    J Vet Intern Med; 2019 May; 33(3):1127-1140. PubMed ID: 30974015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatment on respiratory rate, serum natriuretic peptide concentration, and Doppler echocardiographic indices of left ventricular filling pressure in dogs with congestive heart failure secondary to degenerative mitral valve disease and dilated cardiomyopathy.
    Schober KE; Hart TM; Stern JA; Li X; Samii VF; Zekas LJ; Scansen BA; Bonagura JD
    J Am Vet Med Assoc; 2011 Aug; 239(4):468-79. PubMed ID: 21838584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.